Please use this identifier to cite or link to this item: https://doi.org/10.3389/fnins.2012.00144
DC FieldValue
dc.titleGenome-wide approaches to dissect the roles of RNA binding proteins in translational control: Implications for neurological diseases
dc.contributor.authorKapeli, K
dc.contributor.authorYeo, G.W
dc.date.accessioned2020-10-27T11:24:13Z
dc.date.available2020-10-27T11:24:13Z
dc.date.issued2012
dc.identifier.citationKapeli, K, Yeo, G.W (2012). Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: Implications for neurological diseases. Frontiers in Neuroscience (OCT) : Article 144. ScholarBank@NUS Repository. https://doi.org/10.3389/fnins.2012.00144
dc.identifier.issn16624548
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/181589
dc.description.abstractTranslational control of messenger RNAs (mRNAs) is a key aspect of neurobiology, defects of which can lead to neurological diseases. In response to stimuli, local translation of mRNAs is activated at synapses to facilitate long-lasting forms of synaptic plasticity, the cellular basis for learning, and memory formation.Translation, as well as all other aspects of RNA metabolism, is controlled in part by RNA binding proteins (RBPs) that directly interact with mRNAs to form mRNA-protein complexes. Disruption of RBP function is becoming widely recognized as a major cause of neurological diseases.Thus understanding the mechanisms that govern the interplay between translation control and RBP regulation in both normal and diseased neurons will provide new opportunities for novel diagnostics and therapeutic intervention. As a means of studying translational control, genome-wide methods are emerging as powerful tools that have already begun to unveil mechanisms that are missed by single-gene studies. Here, we describe the roles of RBPs in translational control, review genome-wide approaches to examine translational control, and discuss how the application of these approaches may provide mechanistic insight into the pathogenic underpinnings of RBPs in neurological diseases. © 2012 Kapeli and Yeo.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectamyloid precursor protein
dc.subjectheterogeneous nuclear ribonucleoprotein
dc.subjectmessenger RNA
dc.subjectribonucleoprotein
dc.subjectRNA binding protein
dc.subjectRNA induced silencing complex
dc.subjectsurvival motor neuron protein
dc.subjectTAR DNA binding protein
dc.subjectAlzheimer disease
dc.subjectamyloid plaque
dc.subjectcell isolation
dc.subjectembryonic stem cell
dc.subjectgene expression profiling
dc.subjectgenome
dc.subjecthigh throughput sequencing
dc.subjecthuman
dc.subjectimmunoprecipitation
dc.subjectloss of function mutation
dc.subjectmicroarray analysis
dc.subjectneural stem cell
dc.subjectneurologic disease
dc.subjectnonhuman
dc.subjectopen reading frame
dc.subjectpluripotent stem cell
dc.subjectpolysome
dc.subjectreview
dc.subjectstart codon
dc.subjectstop codon
dc.subjecttranslation regulation
dc.typeReview
dc.contributor.departmentPHYSIOLOGY
dc.description.doi10.3389/fnins.2012.00144
dc.description.sourcetitleFrontiers in Neuroscience
dc.description.issueOCT
dc.description.pageArticle 144
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fnins_2012_00144.pdf967.34 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons